Retatrutide (LY3437943) is a novel synthetic peptide designed as a triple agonist targeting GLP-1, GIP, and glucagon receptors. This 60mg research formulation is intended for metabolic and weight management research applications.
## Product Details
– **Classification:** Triple receptor agonist (GLP-1/GIP/Glucagon)
– **Molecular Weight:** ~5900 Da
– **Purity:** >98%
– **Formulation:** Lyophilized powder
– **Source:** Synthetic
## Research Focus Areas
– GLP-1 receptor activation studies
– GIP receptor modulation
– Glucagon receptor activity
– Weight management research
– Glucose homeostasis
– Energy expenditure mechanisms
Retatrutide represents a new class of incretin-based research peptides with multi-receptor targeting.
For laboratory research only. Not for human consumption.
